Alejandro Losada
Madrid, MD 28770, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
Journal: Molecular aspects of medicine
Published: May 13, 2025
Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 24, 2025
Isolation and Total Synthesis of PM170453, a New Cyclic Depsipeptide Isolated from Lyngbya sp.
Journal: Marine drugs
Published: June 04, 2024
Plitidepsin as an Immunomodulator against Respiratory Viral Infections.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 26, 2023
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis.
Journal: Antiviral research
Published: December 01, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
Journal: Science (New York, N.Y.)
Published: October 28, 2020
Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells.
Journal: Biochemical pharmacology
Published: October 04, 2019
Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival.
Journal: British journal of cancer
Published: April 12, 2018
Dynamic cellular maps of molecular species: Application to drug-target interactions.
Journal: Scientific reports
Published: July 24, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026